5751 to 5800 MCQs for Lab Technician and Technologist Exam Preparation
5000 Plus MCQs for Lab Technician and Technologists are designed to test the knowledge and proficiency of laboratory professionals who work in the field of clinical laboratory science. These questions cover a wide range of topics related to laboratory science, including anatomy, physiology, microbiology, chemistry, and hematology.

If You like then share this to your friends and other social media.
If You have any question and suggestions then please Contact us Here
Questions 5751 to 5800
- a) Sphingomyelin
- b) Ceramide
- c) Cerebroside
- d) Sulphatide
Why other options are incorrect:
- • Sphingomyelin: A type of sphingolipid that contains a phosphocholine or phosphoethanolamine head group.
- • Cerebroside: A sphingolipid with a single sugar residue (glucose or galactose) attached.
- • Sulphatide: A galactosylceramide that contains a sulfate group attached to the sugar.
- a) Chylomicrons
- b) VLDL
- c) LDL
- d) HDL
Why other options are incorrect:
- • Chylomicrons: Primarily composed of triglycerides (nearly 90%), used for the transport of dietary lipids.
- • VLDL: Also high in triglycerides, which are the main component used for delivery to tissues.
- • LDL: Primarily composed of cholesterol esters; it is the major carrier of cholesterol in the blood.
- a) Triglycerides
- b) Phospholipids
- c) Cholesterol
- d) Free fatty acids
Why other options are incorrect:
- • Phospholipids: While present on the surface layer of chylomicrons, they are a minor component compared to triglycerides.
- • Cholesterol: Present in smaller amounts; cholesterol esters are found in the core but do not constitute the majority.
- • Free fatty acids: These are usually transported in the blood bound to albumin, not as the primary cargo within chylomicrons.
- a) 17
- b) 19
- c) 27
- d) 30
Why other options are incorrect:
- • 17: This corresponds to the number of carbons in the gonane (steroid nucleus) structure.
- • 19: This is the number of carbons found in androgens like testosterone.
- • 30: This corresponds to the number of carbons in squalene, the precursor to cholesterol synthesis.
- a) Chylomicrons
- b) VLDL
- c) LDL
- d) HDL
Why other options are incorrect:
- • Chylomicrons: Their primary cargo is dietary triglycerides (not cholesterol).
- • VLDL: Primarily transports endogenous triglycerides synthesized in the liver.
- • HDL: Contains a high proportion of protein and phospholipids, and its main role is “reverse cholesterol transport,” where it clears cholesterol from tissues back to the liver.
- a) Esterified cholesterol
- b) Glycerophospholipids
- c) Triglycerides
- d) Sphingolipids
Why other options are incorrect:
- • Esterified cholesterol: Primarily involved in cellular functions and membrane structure, not energy storage.
- • Glycerophospholipids: These are structural components that form the lipid bilayer of cell membranes.
- • Sphingolipids: These serve as essential components of cell membranes, particularly in the nervous system, rather than energy stores.
- a) Triglycerides
- b) Cerebrosides
- c) Esterified cholesterol
- d) Sphingomyelin
Why other options are incorrect:
- • Triglycerides: Composed of glycerol and three fatty acids, typically not including specialized hydroxylated fatty acids like cerebonic acid.
- • Esterified cholesterol: Composed of cholesterol and a single long-chain fatty acid, typically not cerebonic acid.
- • Sphingomyelin: Contains sphingosine and a fatty acid (usually long-chain), but does not typically contain cerebonic acid as a defining structural component.
- a) Ethanolamine
- b) Choline
- c) Serine
- d) Betaine
Why other options are incorrect:
- • Ethanolamine: Found in Phosphatidylethanolamine (Cephalin), not Lecithin.
- • Serine: Found in Phosphatidylserine.
- • Betaine: A derivative of glycine and choline, but not the base component of the lecithin molecule.
- a) Linoleic acid
- b) α-Linolenic acid
- c) γ-Linolenic acid
- d) Arachidonic acid
Why other options are incorrect:
- • Linoleic acid: An essential omega-6 fatty acid (18:2, n-6).
- • γ-Linolenic acid: An omega-6 fatty acid (18:3, n-6).
- • Arachidonic acid: An omega-6 fatty acid (20:4, n-6), synthesized from linoleic acid.
- a) Linoleic acid
- b) Linolenic acid
- c) Arachidonic acid
- d) Stearic acid
Why other options are incorrect:
- • Linoleic acid: Contains 18 carbon atoms and two double bonds (18:2).
- • Linolenic acid: Contains 18 carbon atoms and three double bonds (18:3).
- • Stearic acid: Contains 18 carbon atoms and is saturated (18:0).
- a) Linoleic acid
- b) α -Linolenic acid
- c) β -Linolenic acid
- d) Arachidonic acid
Why other options are incorrect:
- • Linoleic acid: An 18-carbon fatty acid (C18:2).
- • α-Linolenic acid: An 18-carbon fatty acid (C18:3).
- • β-Linolenic acid: Also known as γ-linolenic acid, it is an 18-carbon fatty acid (C18:3).
- a) Chylomicrons
- b) VLDL
- c) HDL
- d) LDL
Why other options are incorrect:
- • Chylomicrons: Transport dietary triglycerides from the intestine (exogenous pathway), not the liver.
- • HDL: Primarily involved in “reverse cholesterol transport,” moving cholesterol from tissues back to the liver.
- • LDL: Primarily transports cholesterol to peripheral tissues after VLDL has been processed.
- a) Chylomicrons
- b) VLDL
- c) HDL
- d) LDL
Why other options are incorrect:
- • Chylomicrons: Transport dietary lipids from the intestine.
- • VLDL: Primarily transports endogenous triglycerides from the liver.
- • HDL: Performs “reverse cholesterol transport,” moving excess cholesterol from tissues back to the liver (the “good” cholesterol).
- a) Chylomicrons
- b) VLDL
- c) HDL
- d) LDL
Why other options are incorrect:
- • Chylomicrons & VLDL: High levels are associated with high triglycerides, which can increase cardiovascular risk.
- • LDL: Known as “bad cholesterol,” elevated levels promote the deposition of cholesterol in arterial walls, leading to atherosclerosis.
- a) Alanine
- b) Histidine
- c) Cysteine
- d) Proline
Why other options are incorrect:
- • Alanine: A nonessential amino acid that can be synthesized in the body.
- • Cysteine: Generally considered conditionally essential but can be synthesized from methionine.
- • Proline: A nonessential amino acid synthesized from glutamate.
- a) Cysteine
- b) Methionine
- c) Both (A) and (B)
- d) None of these
Why other options are incorrect:
- • Methionine: While it is a sulfur-containing amino acid, it contains a thioether group (-S-CH3), not a free sulphydryl (-SH) group.
- • Both (A) and (B): Incorrect because methionine lacks the -SH group.
- a) N-linked glycoproteins
- b) O-linked glycoproteins
- c) GPI-linked glycoproteins
- d) All of these
Why other options are incorrect:
- • O-linked glycoproteins: These are synthesized by the sequential addition of sugars directly to the hydroxyl groups of serine or threonine residues in the Golgi apparatus, not via a dolichol-pyrophosphate carrier.
- • GPI-linked glycoproteins: While they also utilize a phosphatidylinositol lipid anchor, they follow a different biosynthetic pathway than the dolichol-linked N-glycosylation.
- • All of these: Incorrect, because the dolichol-pyrophosphate intermediate is specific to the N-linked glycosylation pathway.
- a) Asparagine residue
- b) Glutamine residue
- c) Arginine residue
- d) Lysine residue
Why other options are incorrect:
- • Glutamine: Although it contains an amide group, it is not the target for N-linked glycosylation.
- • Arginine: A basic amino acid involved in protein structure and ionic interactions, but not a site for N-linked oligosaccharide attachment.
- • Lysine: While lysine can undergo various post-translational modifications (like ubiquitination or acetylation), it does not participate in N-linked glycosylation.
- a) Cytosol
- b) Mitochondria
- c) Microsomes
- d) All of these
Why other options are incorrect:
- • Mitochondria: While the mitochondria contain enzymes for fatty acid oxidation (beta-oxidation) and elongation of existing fatty acids, they are not the primary site for de novo synthesis.
- • Microsomes: These are involved in the elongation and desaturation of fatty acids, but not the initial de novo synthesis process.
- • All of these: Incorrect, because the central pathway for synthesizing new fatty acids from basic building blocks is localized strictly to the cytosol.
- a) Biotin
- b) Lipoic acid
- c) Pantothenic acid
- d) Folic acid
Why other options are incorrect:
- • Biotin: Used as a cofactor for carboxylase enzymes (e.g., Acetyl-CoA carboxylase), not as part of the ACP.
- • Lipoic acid: Functions as a coenzyme in the pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase complexes.
- • Folic acid: Primarily functions as a donor/acceptor of one-carbon units in various metabolic pathways, not involved in ACP structure.
- a) NADH
- b) NADPH
- c) FADH2
- d) FMNH2
Why other options are incorrect:
- • NADH: Primarily involved in catabolic reactions (like glycolysis and the citric acid cycle) and serves as an electron donor for the electron transport chain to generate ATP.
- • FADH2: Primarily acts as an electron carrier in catabolic processes, such as the oxidation of succinate or beta-oxidation of fatty acids.
- • FMNH2: Like FADH2, it is a flavin-based coenzyme generally involved in oxidation-reduction reactions within the electron transport chain or specific enzymatic oxidations, not fatty acid biosynthesis.
- a) cAMP
- b) Glucagon
- c) Epinephrine
- d) Insulin
Why other options are incorrect:
- • cAMP: Acts as a second messenger that generally triggers protein kinase A (PKA), which phosphorylates and inactivates key enzymes of lipogenesis.
- • Glucagon: Opposes insulin; it raises intracellular cAMP levels and triggers the phosphorylation and inhibition of Acetyl-CoA carboxylase, thereby shutting down lipogenesis.
- • Epinephrine: Like glucagon, it stimulates the breakdown of fats (lipolysis) and inhibits synthesis during times of stress or energy demand.
- a) Biotin
- b) NADH
- c) Pantothenic acid
- d) ATP
Why other options are incorrect:
- • Biotin: Required as a cofactor for acetyl-CoA carboxylase.
- • Pantothenic acid: A component of CoA and the acyl carrier protein (ACP).
- • ATP: Required for the carboxylation of acetyl-CoA to malonyl-CoA.
- a) Allosteric regulation
- b) Covalent modification
- c) Induction and repression
- d) All of these
Why other options are incorrect:
- • Allosteric regulation: Citrate activates ACC, while long-chain fatty acyl-CoA inhibits it.
- • Covalent modification: Phosphorylation generally decreases ACC activity, whereas dephosphorylation activates it.
- • Induction and repression: Hormonal and nutritional signals regulate ACC expression over the longer term.
- a) CoA
- b) FAD
- c) NAD
- d) NADP
Why other options are incorrect:
- • CoA: Required for formation of fatty acyl-CoA and the thiolysis step.
- • FAD: Required for the first oxidation reaction in each cycle.
- • NAD: NAD⁺ is required for the second oxidation reaction in each cycle.
- a) Saturated fatty acids
- b) Monounsaturated fatty acids
- c) Polyunsaturated fatty acids
- d) All of these
Why other options are incorrect:
- • Saturated fatty acids: Undergo the standard β-oxidation pathway.
- • Monounsaturated fatty acids: Can undergo β-oxidation after the double bond is handled by an auxiliary enzyme.
- • Polyunsaturated fatty acids: Can also undergo β-oxidation with additional enzymes such as 2,4-dienoyl-CoA reductase.
- a) Monounsaturated fatty acids
- b) Polyunsaturated fatty acids
- c) Fatty acids with odd number of carbon atoms
- d) None of these
Why other options are incorrect:
- • Monounsaturated/Polyunsaturated: The primary products of β-oxidation for these are Acetyl-CoA units, as the double bonds are simply dealt with by auxiliary enzymes and do not inherently produce 3-carbon units.
- • None of these: Incorrect, because the oxidation of odd-chain fatty acids is specifically known for this unique product.
- a) Acetyl CoA carboxylase
- b) HMG CoA synthetase
- c) HMG CoA reductase
- d) HMG CoA lyase
Why other options are incorrect:
- • Acetyl CoA carboxylase: Primarily involved in fatty acid synthesis, not ketogenesis or cholesterol synthesis.
- • HMG CoA reductase: Specifically involved in cholesterol synthesis as the rate-limiting step; it is not involved in ketogenesis.
- • HMG CoA lyase: Required only for ketogenesis (to break down HMG-CoA into acetoacetate); it is not involved in cholesterol synthesis.
- a) Adipose tissue
- b) Liver
- c) Muscles
- d) Brain
Why other options are incorrect:
- • Adipose tissue: Primarily functions to store and release fatty acids, not to synthesize ketone bodies.
- • Muscles: These tissues utilize ketone bodies as an energy source, but they lack the necessary enzymes (specifically HMG-CoA lyase) to synthesize them.
- • Brain: Like muscles, the brain uses ketone bodies as an alternative fuel source during prolonged fasting or starvation, but it does not synthesize them.
- a) Their synthesis increases in diabetes mellitus
- b) They are synthesized in mitochondria
- c) They can deplete the alkali reserve
- d) They can be oxidized in the liver
Why other options are incorrect:
- • Their synthesis increases in diabetes mellitus: True. Insulin deficiency promotes fatty acid oxidation and ketogenesis.
- • They are synthesized in mitochondria: True. Hepatic ketone bodies are formed in the mitochondrial matrix.
- • They can deplete the alkali reserve: True. Excess ketone bodies contribute to metabolic acidosis by consuming bicarbonate.
- a) It can be synthesised in the human body
- b) It can be synthesized from methionine and lysine
- c) It is required for transport of short chain fatty acids into mitochondria
- d) Its deficiency can occur due to haemodialysis
Why other options are incorrect:
- • It can be synthesised in the human body: True. Carnitine can be synthesized endogenously.
- • It can be synthesized from methionine and lysine: True. Lysine and methionine provide the carbon skeleton and methyl groups required for carnitine synthesis.
- • Its deficiency can occur due to haemodialysis: True. Carnitine can be removed during hemodialysis, potentially causing deficiency.
- a) Oleic acid
- b) Palmitoleic acid
- c) Arachidonic acid
- d) All of these
Why other options are incorrect:
- • Oleic acid: Can be synthesized from stearic acid by Δ9 desaturation.
- • Palmitoleic acid: Can be synthesized from palmitic acid by Δ9 desaturation.
- • Arachidonic acid: Can be synthesized from linoleic acid by further desaturation and elongation.
- a) Palmitic acid
- b) Phytanic acid
- c) Linoleic acid
- d) Fatty acids having an odd number of carbon atoms
Why other options are incorrect:
- • Palmitic acid: A standard saturated fatty acid that undergoes normal β-oxidation.
- • Linoleic acid: An unsaturated fatty acid that can be oxidized via β-oxidation (with the help of isomerases/reductases).
- • Fatty acids with odd carbon atoms: These undergo β-oxidation normally, yielding acetyl-CoA units until a final 3-carbon propionyl-CoA remains.
- a) Leukotrienes
- b) Prostaglandins
- c) Thromboxanes
- d) All of these
Why other options are incorrect:
- • Leukotrienes: Their synthesis decreases because less arachidonic acid is available as substrate.
- • Prostaglandins: Their synthesis decreases due to reduced arachidonic acid release and subsequent COX pathway activity.
- • Thromboxanes: Their synthesis also decreases because they are derived from arachidonic acid through the cyclooxygenase pathway.
- a) Increase in serum triglycerides
- b) Decrease in serum cholesterol
- c) Decrease in serum HDL
- d) Skin lesions
Why other options are incorrect:
- • Increase in serum triglycerides: PUFAs typically do not increase triglycerides; in many cases, they help reduce them.
- • Decrease in serum HDL: While extreme intake might have minor effects, the primary clinically recognized effect of high PUFA intake is the lowering of LDL and total cholesterol, not a significant reduction in protective HDL.
- • Skin lesions: These are generally associated with a deficiency of essential fatty acids, not a high ratio of PUFAs.
- a) Vasodilation
- b) Bronchoconstriction
- c) Platelet aggregation
- d) All of these
Why other options are incorrect:
- • Vasodilation: Thromboxanes act as vasoconstrictors, not vasodilators (Prostacyclin/PGI2 is the primary vasodilator).
- • Bronchoconstriction: While some leukotrienes cause bronchoconstriction, Thromboxane A2 is primarily associated with cardiovascular effects rather than airway constriction.
- • Platelet aggregation: This is the key biological activity of Thromboxane A2, which helps in blood clot formation.
- a) Adipose tissue
- b) Lungs
- c) Platelets
- d) Adenohypophysis
Why other options are incorrect:
- • Lungs: Prostaglandins have several effects in the lungs, but this is not the classic site associated with lowering cAMP in this context.
- • Platelets: Prostaglandins such as prostacyclin (PGI₂) increase cAMP in platelets and inhibit platelet aggregation.
- • Adenohypophysis: Prostaglandins can influence pituitary hormone secretion, but lowering cAMP is not the classic association in this question.
- a) Prostaglandins
- b) Prostacyclins
- c) Thromboxanes
- d) Leukotrienes
Why other options are incorrect:
- • Prostaglandins: These are eicosanoids produced via the cyclooxygenase pathway, not the lipoxygenase pathway responsible for SRS-A.
- • Prostacyclins: A type of prostaglandin (PGI2) involved in vasodilation and inhibiting platelet aggregation.
- • Thromboxanes: Also products of the cyclooxygenase pathway, primarily involved in vasoconstriction and platelet aggregation.
- a) Platelet activating factor
- b) Second messenger for hormones
- c) Lung surfactant
- d) Anti-ketogenic compound
Why other options are incorrect:
- • Platelet activating factor: This is a different class of phospholipid (an ether-linked phospholipid).
- • Second messenger: Second messengers are molecules like cAMP, cGMP, or IP3, not structural phospholipids.
- • Anti-ketogenic compound: This is not the biological role of dipalmitoyl lecithin; it is specifically a structural component of surfactant.
- a) 0.1 N KOH
- b) 0.5 KOH
- c) 0.1 N NaOH
- d) 0.5 NaOH
Why other options are incorrect:
- • Concentration: Using 0.5 N or other concentrations would not correspond to the standard definition of the Reichert-Meissl value.
- • KOH vs NaOH: While 0.1 N NaOH is sometimes used in practice, 0.1 N KOH is the traditional and standard reagent specified in the analytical definition of the R-M number.
- a) Carbon 1
- b) Carbon 2
- c) Both (A) and (B)
- d) None of these
Why other options are incorrect:
- • Carbon 1: Usually carries a saturated fatty acid in glycerophospholipids.
- • Both (A) and (B): PUFA is preferentially located at the sn-2 position rather than both positions.
- • None of these: Incorrect because the PUFA is commonly attached to carbon 2.
- a) Fatty acid from position 1
- b) Fatty acid from position 2
- c) Phosphorylcholine
- d) Choline
Why other options are incorrect:
- • Position 1: Removal of the fatty acid from position 1 is catalyzed by Phospholipase A1, which results in a different isomer.
- • Phosphorylcholine/Choline: Removing these groups would result in different molecules (like phosphatidic acid or diglycerides), not lysolecithin.
- a) Palmitoyl CoA and Choline
- b) Palmitoyl CoA and ethanolamine
- c) Palmitoyl CoA and serine
- d) Acetyl CoA and choline
Why other options are incorrect:
- • Choline/Ethanolamine: These are polar head groups added later in the synthesis of specific sphingolipids like sphingomyelin, but they are not the precursors for the sphingosine backbone.
- • Acetyl CoA: While involved in fatty acid synthesis, it is not the primary precursor used to build the sphingoid base.
- a) Pyridoxal phosphate
- b) NADPH
- c) FAD
- d) NAD
Why other options are incorrect:
- • Pyridoxal phosphate: Required for the serine palmitoyltransferase reaction.
- • NADPH: Provides reducing equivalents during sphingolipid synthesis.
- • FAD: Required for the oxidation step in sphingosine synthesis.
- • NAD: Not required as a coenzyme in the synthesis of sphingosine.
- a) Galactose
- b) Sulphate
- c) Sphingosine
- d) Fatty acid
Why other options are incorrect:
- • Galactose: Commonly present in galactocerebrosides.
- • Sphingosine: Forms the sphingolipid backbone of cerebrosides.
- • Fatty acid: Attached to sphingosine to form the ceramide portion.
- a) Ceramidase
- b) Sphingomyelinase
- c) Arylsulphatase A
- d) Hexosaminidase A
Why other options are incorrect:
- • Ceramidase: Deficiency causes Farber disease.
- • Arylsulphatase A: Deficiency causes Metachromatic leukodystrophy.
- • Hexosaminidase A: Deficiency causes Tay-Sachs disease.
- a) Intestine
- b) Adipose tissue
- c) Liver
- d) Liver and intestine
Why other options are incorrect:
- • Intestine: The intestine is the site of chylomicron synthesis, not their catabolism.
- • Adipose tissue: This tissue is the site for the action of lipoprotein lipase, which removes triglycerides from chylomicrons, but it does not catabolize the remnants themselves.
- • Liver and intestine: While both are involved in lipid metabolism, the specific task of clearing remnants from the circulation is a function performed by the liver.
- a) VLDL
- b) LDL
- c) HDL
- d) Chylomicrons
Why other options are incorrect:
- • VLDL: VLDL is the precursor of its remnant (IDL), not the usual product.
- • HDL: HDL has a separate pathway of synthesis and metabolism.
- • Chylomicrons: Chylomicrons transport dietary lipids and are formed in intestinal cells.
- a) Apo A specific
- b) Apo B-48 specific
- c) Apo C specific
- d) Apo E specific
Why other options are incorrect:
- • Apo A: Primarily associated with HDL.
- • Apo B-48: A structural protein unique to chylomicrons and their remnants, but it does not serve as the ligand for hepatic uptake.
- • Apo C: Involved in the activation or inhibition of lipoprotein lipase, not in the hepatic uptake of remnants.
- a) Apo A
- b) Apo C
- c) Apo E
- d) Apo C and Apo E
Why other options are incorrect:
- • Apo A: Present in nascent HDL and is the major structural apolipoprotein of HDL.
- • Apo C: Nascent intestinal HDL initially lacks Apo C.
- • Apo E: Nascent intestinal HDL initially lacks Apo E.
Answer Key Summary
The questions are typically designed to assess the technical skills and knowledge required for the laboratory profession, including the ability to analyze laboratory test results, perform laboratory procedures, and maintain laboratory equipment.
To prepare for these MCQs, candidates should have a thorough understanding of the key concepts and principles of laboratory science. They should also be familiar with common laboratory equipment and procedures, as well as laboratory safety protocols.
Candidates may also benefit from studying specific laboratory science textbooks or taking online courses that cover the material tested in the MCQs. Additionally, practicing sample MCQs and reviewing the answers can help candidates identify areas where they may need to improve their knowledge or skills.
Overall, the MCQs for lab technologists are designed to be challenging and comprehensive, requiring candidates to demonstrate a high level of proficiency in the field of laboratory science.

Virulent factor in pneumococcus is?
Capsule
Emdotoxins
Cell wall
Mesosomes
The answer is capsule but you have given cell wall .